A Thymosin Alpha-1 COA (Certificate of Analysis) provides verifiable, lot-specific analytical documentation detailing peptide purity, molecular identity, and safety profiles. Each certificate verifies reverse-phase high-performance liquid chromatography (RP-HPLC) purity exceeding 99%, electrospray ionization mass spectrometry (ESI-MS) sequence validation, and quantitative LAL endotoxin testing for rigorous laboratory research applications.
A Thymosin Alpha-1 COA (Certificate of Analysis) provides verifiable, lot-specific analytical documentation detailing peptide purity, molecular identity, and safety profiles. Each certificate verifies reverse-phase high-performance liquid chromatography (RP-HPLC) purity exceeding 99%, electrospray ionization mass spectrometry (ESI-MS) sequence validation, and quantitative LAL endotoxin testing for rigorous laboratory research applications.
In analytical chemistry and preclinical peptide research, a comprehensive Certificate of Analysis (COA) serves as the primary standard for material verification. A rigorous thymosin alpha-1 coa provides essential data regarding chemical identity, total purity, counterion content, moisture levels, and biological contaminant testing. For principal investigators and lab managers, validating these analytical parameters prior to initiating in vitro or animal studies is necessary to ensure experimental reproducibility and eliminate confounding variables caused by synthesis byproducts.
When inspecting a Thymosin Alpha-1 20mg COA, researchers must confirm that the document reflects batch-specific testing from an independent, ISO 17025 accredited laboratory. Standard manufacturer documentation should highlight two central analytical methodology outputs: High-Performance Liquid Chromatography (HPLC) for purity quantification and Mass Spectrometry (MS) for exact molecular weight confirmation. PX1 Research mandates third-party COA validation across all production lots to maintain strict compliance with institutional research standards.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard method for determining the chromatographic purity of synthetic peptides. During RP-HPLC testing of Thymosin Alpha-1, the peptide sample is eluted through a non-polar stationary phase using a polar mobile phase gradient (typically water and acetonitrile containing trifluoroacetic acid). As the compound passes through the UV detector at a wavelength of 214 nm or 220 nm, peptide bonds absorb light, generating a distinct chromatographic peak.
A compliant report on a thymosin alpha-1 coa will display a single dominant target peak representing Thymosin Alpha-1, with minor secondary peaks representing trace deletion sequences or truncated peptides. Relative purity is calculated as the area under the curve (AUC) of the main peak divided by the total integrated peak area. Qualified reagents should consistently exhibit an HPLC purity profile of equal to or greater than 98.0%, ensuring that non-target peptide impurities do not interfere with cell culture media or receptor binding assays.
While RP-HPLC quantifies purity, it cannot independently verify that the target peptide possesses the correct primary amino acid sequence. Mass Spectrometry—specifically Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF)—is deployed to confirm the precise molecular mass of the compound. You can learn more about these analytical methods in our guide to peptide purity testing via HPLC and MS.
Thymosin Alpha-1 is a 28-amino acid synthetic peptide with an N-terminal acetylated structure, yielding a theoretical molecular weight of 3108.3 Da. On an official mass spectrum included within the COA, the observed mass peak [M+H]+ must align with the theoretical mass within tight mass tolerance limits (typically ±1.0 Da). Matching mass spectra guarantees the absence of major amino acid substitutions, racemization errors, or incorrect sequence synthesis.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—pose a significant contamination risk in cell culture and preclinical models. Even trace endotoxin levels can trigger unintended immunogenic responses in primary splenocyte or lymphocyte assays, distorting experimental outcomes. Consequently, testing protocols detailed on a thymosin alpha-1 coa must include a chromogenic or turbidimetric Limulus Amebocyte Lysate (LAL) assay.
Standard laboratory specifications require endotoxin levels to remain strictly under defined thresholds, typically recorded as < 0.01 EU/mg or < 0.1 EU/mg. Reviewing our technical notes on endotoxin testing in laboratory peptides provides context on how low endotoxin levels safeguard sensitive in vitro cultures and prevent non-specific baseline activation of toll-like receptor (TLR) pathways.
When establishing research protocols, comparative chemical evaluation across similar research compounds ensures consistency across experimental groups. Laboratories frequently cross-reference analytical criteria across multiple synthetic peptides in their inventory to verify vendor quality control protocols across different peptide lengths and molecular structures.
For example, comparing the analytical criteria of Thymosin Alpha-1 20mg against other immunomodulatory or regenerative peptides such as Thymosin Beta-4 10mg and BPC-157 10mg illustrates distinct structural and testing requirements. While Thymosin Alpha-1 is a 28-residue peptide requiring precise acetylation monitoring, Thymosin Beta-4 is a longer 43-amino acid sequence demanding highly controlled elution gradients during HPLC analysis. Similarly, pentadecapeptide BPC-157 requires specific counterion verification to maintain stability during aqueous reconstitution. Exploring our full catalog of research peptides allows lab teams to review standardized analytical documentation across diverse compound families.
Analytical reports are only as reliable as the quality systems of the manufacturing and testing facilities behind them. Every lot of peptide supplied by PX1 Research is synthesized in state-of-the-art, GMP-compliant facilities located within the United States. Following synthesis and lyophilization, independent samples are submitted to ISO 17025 accredited analytical laboratories to execute independent quality verification.
Lot traceability is embedded into every step of our supply chain. Each individual vial features a specific lot number linked directly to its corresponding mass spectrum, HPLC chromatogram, and endotoxin report. Investigators can audit the complete history of their material, ensuring that every batch utilized in longitudinal studies maintains identical purity profiles and physical characteristics.
Thymosin Alpha-1 is supplied as a sterile, lyophilized (freeze-dried) powder in a 20mg vial format to optimize shelf life and chemical stability. Reconstitution must be performed within a certified laminar flow hood using aseptic technique to prevent microbial contamination. Standard laboratory reconstitutions utilize Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Normal Saline (0.9% NaCl), depending on downstream assay compatibility.
To reconstitute, slowly direct the solvent against the inner glass wall of the vial rather than spraying directly onto the lyophilized cake. Allow the solvent to gently wet the peptide matrix, then gently swirl the vial until the solution is completely clear and colorless. Avoid vigorous vortexing or rapid agitation, as high mechanical shear forces can induce peptide aggregation or denaturation. Detailed handling parameters and molecular stability guides are available in our laboratory research hub.
Lyophilized Thymosin Alpha-1 exhibits superior stability when stored at desiccation temperatures of -20°C or -80°C, protected from direct light exposure. Under these conditions, the un-reconstituted peptide retains structural integrity and target purity for up to 24 months from the manufacturing date recorded on the COA.
Once reconstituted into an aqueous solution, the peptide should be aliquoted into single-use polypropylene microtubes to prevent repeated freeze-thaw cycles, which degrade peptide bonds. Reconstituted aqueous solutions remain stable at 2°C to 8°C for up to 30 days when prepared with bacteriostatic solvents, or up to 3 to 6 months when stored frozen at -80°C. Researchers requiring high-volume supplies for ongoing institutional projects can access tiered pricing via a wholesale laboratory account.
In vitro and animal model studies indicate that Thymosin Alpha-1 interacts with pattern recognition receptors, particularly Toll-like Receptor 4 (TLR4) and Toll-like Receptor 7 (TLR7), initiating downstream signal transduction cascades involving NF-κB and MyD88. Preclinical literature demonstrates its utility in evaluating dendritic cell maturation, T-helper 1 (Th1) lineage differentiation, and natural killer (NK) cell cytotoxic responses.
To review full mechanisms of action, cell signaling assays, and preclinical research citations, visit our detailed technical document on Thymosin Alpha-1 research mechanisms. All compounds supplied by PX1 Research are intended strictly for in vitro laboratory assays, biochemical analyses, and non-human animal research models.
To maintain chain-of-custody integrity and product viability, PX1 Research operates centralized distribution centers in California and Arizona. Orders placed Monday through Friday prior to cutoff times receive same-day fulfillment, minimizing transit times and temperature fluctuations.
Every shipment includes lot-matched documentation, secure temperature-controlled packaging when required, and direct access to digital analytical reports. Lab procurement teams can rely on PX1 Research for consistent lot-to-lot reproducibility, transparent testing methodologies, and rapid delivery for high-throughput research workflows.
What is a thymosin alpha-1 coa?
A Thymosin Alpha-1 COA (Certificate of Analysis) is a batch-specific quality assurance document produced by an independent analytical laboratory. It details the precise HPLC chromatographic purity, mass spectrometry identity confirmation, physical appearance, and endotoxin levels for a specific lot of synthetic Thymosin Alpha-1 peptide.
Where can I download a lot-specific thymosin alpha-1 coa?
Batch-specific COAs for PX1 Research compounds are accessible directly on the individual product page for Thymosin Alpha-1 20mg or by contacting technical support with your vial lot number.
What standard of HPLC purity is reported on a thymosin alpha-1 coa?
PX1 Research mandates that every batch of Thymosin Alpha-1 exhibit a minimum of 98.0% purity as determined by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), with most lots exceeding 99.0% total purity.
How is molecular identity confirmed on a thymosin alpha-1 coa?
Molecular identity is verified using Mass Spectrometry (ESI-MS or MALDI-TOF). The observed molecular mass must match the theoretical mass of acetylated Thymosin Alpha-1 (3108.3 Da) within a ±1.0 Da tolerance window.
What endotoxin limits are acceptable on a research peptide COA?
For preclinical research applications, bacterial endotoxin levels must test below 0.1 EU/mg (and typically < 0.01 EU/mg) via quantitative LAL chromogenic assay to prevent non-specific immune baseline activation in cell culture models.
How should a 20mg vial of Thymosin Alpha-1 be reconstituted in the lab?
Reconstitution should be conducted in a laminar flow hood using sterile Bacteriostatic Water or normal saline. Add the solvent slowly down the inner vial wall and gently swirl until dissolved. Avoid vigorous agitation or vortexing.
What is the shelf life and proper storage temperature for lyophilized Thymosin Alpha-1?
Lyophilized Thymosin Alpha-1 is stable for up to 24 months when stored at -20°C or -80°C in a desiccated, light-protected environment. Reconstituted liquid aliquots should be stored at 2°C to 8°C for short-term use or -80°C for long-term storage.
How does Thymosin Alpha-1 differ structurally from Thymosin Beta-4?
Thymosin Alpha-1 is a 28-amino acid acetylated peptide derived from prothymosin alpha, focusing primarily on TLR signaling pathways. Thymosin Beta-4 is a 43-amino acid peptide that acts as an actin-sequestering protein involved in cell migration and tissue remodeling.
Can academic and corporate institutions establish wholesale peptide accounts?
Yes, research institutions, universities, and biotech facilities can establish dedicated wholesale accounts with PX1 Research to access bulk volume pricing, batch reservations, and custom synthesis options.
Are PX1 Research peptides manufactured in the United States?
Yes. All PX1 Research peptides are manufactured in US-based, GMP-compliant facilities and undergo independent purity and endotoxin testing at ISO 17025 accredited analytical laboratories.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.